The Ministry of Health of the government of the Community of Valencia has begun to test a vaccine against avian influenza among children of various health centers.

The first phase of this project has been closed and attended by children of 6-9 years. The second will be tested in children between the ages of 3 and 5 years.

pandemia. It is the first global test of this type of vaccine, H5N1, in order to prove its effectiveness in reducing the numbers involved in a possible pandemic.

The trial is being conducted pediatricians members of the Institute for Vaccine Valencia (VIVA). The pharmaceutical company that has developed the vaccine is GSK.